Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Arnau
Arnau Panosa, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110270846 | ELECTRONICALLY LINKING AND RATING TEXT FRAGMENTS - In one embodiment, a first text fragment is made available for copying from a fragment repository. The first text fragment is electronically linked to a second text fragment that is a copy of the first text fragment, the second text fragment included in a container external to the fragment repository. A rating is provided for a derivative of the second fragment created within the container. A third text fragment that is a derivative of the second text fragment is received at the fragment repository. The first and third text fragments are electronically linked, and the third text fragment is made available for copying. | 11-03-2011 |
Arnau Pla Calvet, Sant Cugat Del Valles(barcelona) ES
| Patent application number | Description | Published |
|---|---|---|
| 20110104802 | PROCEDURE FOR THE UNDIFFERENTIATED OR MYELOID LINEAGE BIASED EXPANSION OF HAEMATOPOIETIC STEM CELLS FROM UMBILICAL CORD BLOOD, MOBILIZED PERIPHERAL BLOOD OR BONE MARROW - Procedure for the undifferentiated or myeloid lineage biased expansion of haematopoietic stem cells coming from umbilical cord blood, mobilized peripheral blood or bone marrow. | 05-05-2011 |
Arnau Pla Calvet, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110201111 | METHOD FOR OBTAINING CONNECTIVE MESENCHYMAL STEM CELLS FROM THE MONONUCLEAR FRACTION OF HUMAN BONE MARROW - The present invention relates to a method for obtaining connective mesenchymal stem cells from the mononuclear fraction of human bone marrow cells using type AB human serum as a supplement. Said method includes the steps of obtaining said mononuclear fraction of bone marrow, the step of recovering and pre-expanding the connective stem cells and the step of expanding the connective stem cells until obtaining the clinical dose required for the therapeutic use thereof. | 08-18-2011 |
